Department of Pathology, Gyeongsang National University School of Medicine, Jinju, Republic of Korea.
Department of Pathology, Gyeongsang National University Hospital, Jinju, Korea.
Anticancer Res. 2020 Jun;40(6):3203-3208. doi: 10.21873/anticanres.14301.
BACKGROUND/AIM: We aimed to evaluate the characteristics of gastric carcinoma with high excision repair cross complementing 1 (ERCC1) expression and the prognostic value of ERCC1 expression.
ERCC1 expression was evaluated by immunohistochemistry in 309 surgically resected gastric carcinoma specimens using a tissue microarray. Cancer-related survival was analysed using competing risk analysis.
Compared to ERCC1-low gastric carcinomas, ERCC1-high gastric carcinomas showed less local invasion (p=0.0013), lower N stage (p=0.0302), earlier pTNM stage (p=0.0003), and less frequent recurrence (p=0002). Patients with ERCC1-high gastric carcinoma showed lower cumulative incidence function estimate of cancer-related death [3.37; 95% confidence intervaI (CI)=0.89-8.75] than did those with ERCC1-low gastric carcinoma (17.12; 95% CI=12.24-22.69; p-value by Gray's test=0.0012). Adjusted proportional sub-distribution hazard ratio for cancer-related death in the patients with ERCC1-high tumour was 0.272 (95% CI=0.084-0.878; p=0.0295).
High ERCC1 expression may be an independent positive prognostic marker for gastric carcinoma.
背景/目的:本研究旨在评估高切除修复交叉互补基因 1(ERCC1)表达的胃癌的特征及其 ERCC1 表达的预后价值。
采用组织微阵列免疫组化法检测 309 例手术切除的胃癌标本中 ERCC1 的表达。采用竞争风险分析评估癌症相关生存情况。
与 ERCC1 低表达的胃癌相比,ERCC1 高表达的胃癌侵袭性更低(p=0.0013),N 分期更低(p=0.0302),pTNM 分期更早(p=0.0003),复发率更低(p=0.0002)。与 ERCC1 低表达的胃癌患者相比,ERCC1 高表达的胃癌患者的癌症相关死亡累积发生率估计值较低[3.37;95%置信区间(CI)=0.89-8.75](p 值为 Gray 检验=0.0012)。校正后的癌症相关死亡比例风险亚分布比(hazard ratio,HR)在 ERCC1 高肿瘤患者中为 0.272(95% CI=0.084-0.878;p=0.0295)。
ERCC1 高表达可能是胃癌的一个独立的阳性预后标志物。